CN Patent

CN101450049A — 药物组合物

Assigned to Ferring International Center (switzerland) S A · Expires 2009-06-10 · 17y expired

What this patent protects

本发明提供一种包含多库酯；渗透性缓泻药；和苯甲酸盐的药物组合物。

USPTO Abstract

本发明提供一种包含多库酯；渗透性缓泻药；和苯甲酸盐的药物组合物。

Drugs covered by this patent

sodium-phosphate-dibasic-anhydrous (SODIUM PHOSPHATE, DIBASIC, ANHYDROUS)

Patent Metadata

Patent number: CN101450049A
Jurisdiction: CN
Classification: —
Expires: 2009-06-10
Drug substance claim: No
Drug product claim: No
Assignee: Ferring International Center (switzerland) S A
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.